Dibekacin Sulfate
Arbekacin Sulfate
Dibekacin Alkali

Arbekacin Alkali

Mycophenolic Acid
Mycophenolate Mofetil
Vancomycin hcl
Intermediate for TMC-114 of AZT
Teicoplanin
Vinorelbine Ditartrate
Tanshinone II A

Fuzhou Borni Pharmaceutical Sci.&Tech. Co.,Ltd

Fuzhou Borni Pharmaceutical Sci.&Tech. Co.,Ltd is a new established pharmaceutical research&development hi-tech enterprises. Borni was born in April, 2005 in the Biomedical Hi-tech Incubator of Jinshan Sci&Tech Garden . Borni built a 1000m2pharmaceutical research&development center according to GLP requirement,owning first-class, advanced equipped research center , laboratory and middle-scale production platform by pulling into RMB 10 million investment.

Our R&D center

- Middle-scale production platform for New Drug
  Development
- Medicinal Chemistry study center
- Microorganism fermentation and transforming study center
- Microorganism strain reserving and culturing laboratory
- Separating and Distilling laboratory
- New formulation study and application laboratory
- Instrumental and chemical analysis laboratory
- 100 degree Clear&Sterile laboratory under 10,000degree streamline laminar flow

Our new drug R&D team

- 50 R&D employees, of which, 90% are Bachelor's Degree.
- of which, 51% are such expertise as Returned Oversea Chinese Person, Senior Engineer and Licensed Pharmacist.
- More than 10 contracted researchers and post-doctors

Our strategic partners:

- Partnership has been established with some key university and R&D centers in domestic and abroad

Fuzhou Borni Pharmaceutical Scl.& Tech.Co.,Ltd.  Add : 3F .,7 TH Building,No.7, North Jinzhou Road ,Jinshan, Fuzhou ,350002, China
Tel : 0086-591-88073811,88073803 Fax : 0086-591-88073807  E-mail: marketing@borni.com.cn
Supported by ChemNet ChinaChemNet Toocle